Form 4: PTC Therapeutics CFO Pierre Gravier Sells Shares to Cover Tax Obligations

Pierre Gravier, CFO of PTC Therapeutics, sold 2,269 shares of common stock on July 16, 2024, to cover tax obligations related to the vesting of restricted stock units.

Summary

• On July 16, 2024, Pierre Gravier, the Chief Financial Officer of PTC Therapeutics, sold 2,269 shares of the company's common stock.
• The sale was executed at a price of $34.024 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of 6,500 restricted stock units (RSUs) from a grant made on July 13, 2023.
• Following the transaction, Gravier directly owns 53,531 shares of PTC Therapeutics.
• The sale was automatically executed pursuant to an irrevocable sell to cover election.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes on vested RSUs) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine financial activity and doesn't necessarily indicate a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the impact is likely minimal given the routine nature of the transaction.

Key Dates